Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 6/20 | 0.51 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.42 |
| ▸ | PLAU | P00749 | 1/20 | 0.41 |
| ▸ | XDH | P47989 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18800413 | 0.91 | BTK (0.62) | BTKMCL1PLAUXDHALDH1A1 | |
| SCHEMBL18800685 | 0.90 | BTK (0.64) | BTKMCL1SMN1; SMN2 | |
| SCHEMBL16168193 | 0.89 | PARP10 (0.51) | BTKMCL1XDHSCN9A | |
| SCHEMBL16168190 | 0.89 | BTK (0.54) | BTKALDH1A1SCN9A | |
| SCHEMBL18800407 | 0.88 | F2 (0.49) | BTKMCL1PLAUXDH | |
| SCHEMBL18800779 | 0.88 | XDH (0.47) | BTKMCL1XDHSCN9A | |
| SCHEMBL18800673 | 0.88 | PGR (0.53) | BTKPLAUMEN1KMT2ANPSR1 | |
| SCHEMBL16168188 | 0.88 | ALDH1A1 (0.53) | BTKMCL1XDHALDH1A1GLA | |
| SCHEMBL18800677 | 0.87 | MCL1 (0.46) | BTKMCL1XDHMEN1KMT2A | |
| SCHEMBL18800683 | 0.86 | SCN9A (0.47) | BTKMCL1PLAUXDHSCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2789615-B1 | Azaindazoles as Btk kinase modulators and use thereof | BRISTOL MYERS SQUIBB CO (US) | 2017-05-03 | — | — | EP | disclosed |